VR and music: a new way to ease chemo stress?
NCT ID NCT06305117
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using virtual reality (VR) and music during chemotherapy sessions is practical and helpful for breast cancer patients. Sixty patients were offered VR headsets with calming music and videos while receiving chemo. The goal was to see if patients would use it and if it could reduce anxiety, pain, and nausea. Results will guide a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- virtual reality and music distraction strategy
- What this could lead to
- If this approach works, it could offer a drug-free way to help breast cancer patients feel less anxious and more comfortable during chemotherapy.
- What could go wrong
- This is a small, early feasibility study with only 60 patients and no comparison group. It cannot prove the strategy actually improves quality of life—just whether it's practical to use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Histologically confirmed diagnosis of breast cancer; * Any disease stage; * Patient must be receiving (i.e., with at least 4 remaining cures) or about to start palliative or curative neoadjuvant or adjuvant chemotherapy for their breast cancer at Centre Léon Bérard; * Willingness and ability to comply with the study requirements; * Patient must be covered by a medical insurance; * Patient must understand, speak, read and write French. Exclusion Criteria: * History of condition contraindicating the use of virtual reality (e.g., epilepsy, severe motion sickness); * Brain metastases; * Any medical or psychosocial condition that would compromise the patient's compliance to the study procedures or would likely interfere with the completion of Patient-Reported Outcomes; * Patients under tutorship or curatorship; * Patients already included in another clinical trial ongoing at Centre Léon Bérard.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Léon Bérard
Lyon, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?